Literature DB >> 9697743

The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs.

P Lanotte1, F Dubois, S Le Pogam, C Guerois, B Fimbel, Y Bacq, Y Gruel, A Goudeau, F Barin.   

Abstract

Several studies have reported the spontaneous loss of hepatitis C virus (HCV) antibodies in HCV-exposed persons. However, the relationship between seroreversion and spontaneous virus clearance has yet to be precisely determined in a single homogeneous population of untreated immunocompetent patients. In this study, 32 human immunodeficiency virus-seronegative hemophiliacs who had been exposed to HCV were followed for a mean duration of 141 months; 22 remained chronic carriers (68.8%). All but 1 of the nonviremic patients (90.0%) showed partial (8 cases) or complete (2 cases) seroreversion. In contrast, all but 1 of the viremic patients (95.1%) had a stable serologic profile when analyzed by a recombinant immunoblot assay. The results indicate that any HCV antibody-positive immunocompetent patient with no detectable serum HCV RNA and normal alanine aminotransferase values and whose serial samples show a progressive decrease in the level of HCV antibodies present may be considered as having a resolved infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9697743     DOI: 10.1086/517473

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Use of an anti-hepatitis C virus (HCV) IgG avidity assay to identify recent HCV infection.

Authors:  Catherine Gaudy-Graffin; Gérard Lesage; Isabelle Kousignian; Syria Laperche; Annie Girault; Frédéric Dubois; Alain Goudeau; Francis Barin
Journal:  J Clin Microbiol       Date:  2010-07-07       Impact factor: 5.948

2.  HCV viremia is associated with drug use in young HIV-1 and HCV coinfected pregnant and non-pregnant women.

Authors:  Georgia B Nikolopoulou; Marek J Nowicki; Wenbo Du; James Homans; Alice Stek; Francoise Kramer; Andrea Kovacs
Journal:  Addiction       Date:  2005-05       Impact factor: 6.526

3.  Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population.

Authors:  L A Kondili; P Chionne; A Costantino; U Villano; C Lo Noce; F Pannozzo; A Mele; S Giampaoli; M Rapicetta
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

4.  Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa.

Authors:  Daniel Candotti; Jillian Temple; Francis Sarkodie; Jean-Pierre Allain
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

5.  Role of signal-to-cut-off ratios of anti-hepatitis C virus antibody by enzyme immunoassays along with ID-NAT for screening of whole blood donors in India.

Authors:  Satyam Arora; Veena Doda
Journal:  Asian J Transfus Sci       Date:  2016 Jan-Jun

6.  Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia.

Authors:  Yeon Seok Seo; Eun Suk Jung; Jeong Han Kim; Young Kul Jung; Ji Hoon Kim; Hyonggin An; Hyung Joon Yim; Jong Eun Yeon; Kwan Soo Byun; Chang Duck Kim; Ho Sang Ryu; Soon Ho Um
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 3.165

7.  Absence of seroreversion in 80 HAART-treated HIV-1 seropositive patients with at least five-years undetectable plasma HIV-1 viral load.

Authors:  Marion Cornelissen; Suzanne Jurriaans; Jan M Prins; Margreet Bakker; Antoinette C van der Kuyl
Journal:  AIDS Res Ther       Date:  2006-02-16       Impact factor: 2.250

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.